Medical expert of the article
New publications
Inoculations of healthy children
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Hemophilus type b (Hib) infection - vaccinations against it have been recommended by the Ministry of Health for more than 10 years, the cost of vaccination has decreased significantly during this time (vaccine Act-Hib and Hiberici), the Hib component is included in the recently registered Pentaxim vaccine (DTP + IPV + Hib), so the prevention of this infection is quite affordable and desirable - both within the framework of regional and individual financing.
Whooping cough. As shown in the corresponding section, the increase in the incidence of pertussis in school and adolescence caused many countries to include in the calendar a second booster vaccine against pertussis with acellular vaccine. The experience of the Sverdlovsk region shows that the introduction of the Infanriks vaccine before the school (at the age of) reduces the incidence of whooping cough, incl. Intensity of infection of children of the first year of life. Inclusion of this vaccine at the regional level, as well as on an individual basis, is highly desirable before inclusion in the National Calendar.
Influenza - these vaccinations are shown not only to organized children, as it is conditioned by the National Calendar, but to all children, starting from the second half of life to adults, especially in the framework of family vaccination.
Hepatitis A - in conditions of Russia with a significant rural sector and shuttle migration of the city-village, in general, the late (in adolescence) growth of seropositivity is fully justified by the massive vaccination of children, at least, urban. The experience of the Sverdlovsk region shows the possibility of practical elimination of this infection by mass vaccination. Beginning of vaccination is possible with a 2-year life, however, taking into account the vaccination density in the 2nd year, it can be performed starting from 3 years.
Chickenpox. The registration of the vaccine Varilrix opens the way to its use on a regional and individual basis - this usually infrequent infection is the most common, which causes economic losses that surpass those of other managed infections.
Rotavirus infection - the main causative agent of diarrhea in early childhood - has recently become manageable, but the first results of its massive use in the US have shown the possibility of a sharp reduction in morbidity. The expected registration in Russia of the Rotaryx vaccine will allow its use before introduction into the National Calendar.
Papillomovirus infection is the main cause of cervical cancer, which takes thousands of women's lives every year, has also become manageable since 2006, Gardasil and Cervarix vaccines are licensed in Russia and are recommended by the society of obstetrician-gynecologists for use in teenage girls (from age 12) and young women (age 26 years).
Pneumococcal infection. Vaccination of 23-valent polysaccharide vaccine Pnevmo23, immunogenic from the age of 2 years, was recommended by the Ministry of Health and Social Development of the following contingents of healthy individuals:
- Persons who are in special conditions or special social institutions or organized collectives (kindergartens, schools, children's homes, army and other military collectives - it is better 3 weeks before admission to the team immediately after admission).
- Healthy children from 2 years of age to reduce the risk of ARI, especially before entering organized groups (kindergartens and schools).
The anticipated registration of conjugated 7-valent vaccine Preven in 2009 opens the prospect of mass vaccination to control this most common bacterial infection.